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Antigen 43 (Ag43), a self-recognizing outer membrane protein of Escherichia coli, has been converted into an
efficient and versatile tool for surface display of foreign protein segments. Ag43 is an autotransporter protein
characterized by the feature that all information required for transport to the outer membrane and secretion
through the cell envelope is contained within the protein itself. Ag43 consists of two subunits ( and ), where
the -subunit forms an integral outer membrane translocator to which the -subunit is noncovalently at-
tached. The simplicity of the Ag43 system makes it ideally suited as a surface display scaffold. Here we
demonstrate that the Ag43 -module can accommodate and display correctly folded inserts and has the ability
to display entire functional protein domains, exemplified by the FimH lectin domain. The presence of heter-
ologous cysteine bridges does not interfere with surface display, and Ag43 chimeras are correctly processed into
- and -modules, offering optional and easy release of the chimeric -subunits. Furthermore, Ag43 can be
displayed in many gram-negative bacteria. This feature is exploited for display of our chimeras in an atten-
uated Salmonella strain.
The ability of cells to display proteins on the surface is
essential in a wide range of biological phenomena, such as
adhesion, colonization, biofilm formation, cell-cell recognition,
signal transduction, and immunoreactions. In recent years, a
variety of expression systems have been developed for display
of heterologous peptides on cell surfaces. By grafting foreign
proteins to naturally occurring surface proteins, it has been
possible to express chimeric proteins on the surfaces of bacte-
riophages, bacteria, and yeast cells (4, 16, 24). Cells displaying
heterologous peptides and proteins have led to the design of
recombinant vaccines, reagents for diagnostics, whole-cell bio-
catalysts and bioadsorbants, and systems for combinatorial li-
brary screening.
Many different types of surface proteins of gram-negative
bacteria have been used to display foreign peptides; these
surface proteins include flagellin (36, 41), fimbriae (reviewed
in reference 30), LamB (5, 6, 32), OmpA (13), FhuA (12),
PhoE (1), peptidoglycan-associated lipoprotein (10, 14),
S-layer protein (2), OprI (8), immunoglobulin A (29, 51, 52),
AIDA-I (34, 37), and VirG (50). One of the problems usually
encountered with such display systems is the limited size of
heterologous grafts that can be displayed without detrimental
effects on the structure and/or function of the carrier protein
and often the low copy number of the carrier protein. Also,
expression of many, if not most, surface proteins is often re-
stricted to confined host backgrounds, which can limit the
versatility of corresponding display systems. Clearly, an ideal
display system should combine the ability to accommodate
large inserts with a high copy number and a broad host range.
Antigen 43 (Ag43) is a surface protein of Escherichia coli
present at 50,000 copies per cell (42). The protein is a mem-
ber of the autotransporter family, for which all information
required for transport to the outer membrane and secretion
through the cell envelope is contained in the protein itself (22).
Ag43 is encoded by the flu gene, situated at 43 min on the E.
coli chromosome (9). The expression is phase variable due to
the concerted action of the Dam methylase (positive regula-
tion) and the global regulator OxyR (negative regulation) (18,
23, 53). Ag43 is synthesized as a precursor of 1,039 amino
acids, which is processed into a mature form consisting of two
subunits,  and , of 499 and 488 amino acid residues, respec-
tively (19, 23). The -subunit integrates into the outer mem-
brane, where it forms a pore-like -barrel structure in analogy
with its AIDA-I homologue (23, 38). The -subunit reaches
the cell exterior assisted by the -subunit and remains attached
to the cell surface, presumably through noncovalent interac-
tion with the -subunit; however, it can easily be detached by
brief heating to 60°C.
Ag43 has been found to induce characteristic surface prop-
erties on host cells, such as autoaggregation and a frizzy colony
morphology (19, 20). Furthermore, we recently demonstrated
that Ag43 is involved in bacterial biofilm formation (27, 28).
Another important property of Ag43 is that, albeit of E. coli
ancestry, it can be expressed in a fully functional form in a
broad spectrum of gram-negative bacteria, including Pseudo-
monas fluorescens, Klebsiella pneumoniae, Enterobacter cloacae,
Serratia liquefaciens, and many others (27; unpublished data).
These attributes make Ag43 a highly versatile protein and
potentially an ideal candidate for display of heterologous se-
quences on the surface of a broad range of organisms.
In this report we investigate the use of Ag43 for display of
different immunogenic epitope tags and entire protein do-
mains. Furthermore, due to the broad host range of Ag43, we
examine the ability to express Ag43 chimeras in a well-charac-
terized attenuated Salmonella vaccine strain.
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MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Strains and plasmids are
listed in Table 1. In this study we used E. coli K-12 strain HEHA16 (leu lysA metE
proB purE thi trp str supE fhuA fim::kan flu) (27). Salmonella enterica serovar
Typhimurium SL5325 is a lipopolysaccharide-deficient (rfaJ) derivative of
SL5316 (aroA) (39). SL5316 is of the FIRN (rhamnose negative, inositol nega-
tive, and permanently nonfimbriate) biotype and unable to produce type 1
fimbriae (11). Cells were grown at 37°C on solid or in liquid Luria-Bertani (LB)
medium supplemented with the appropriate antibiotics unless otherwise stated.
Recombinant DNA techniques. The flu gene was amplified by PCR from a
plasmid preparation of pHHA147 (27) with primers KK70 (5-CGCGCTCGA
GATAATAAGGAAAAGCTATGAAC) and KK39 (5-CGGCGAAGCTTCT
GTCAGAAGGTCAC) containing XhoI and HindIII sites, respectively. The
resulting PCR products were digested with XhoI and HindIII and inserted into
the XhoI and HindIII sites of the pBAD/myc-HisA plasmid to produce pKKJ143
(Fig. 1). In this construct, expression of the flu gene is under control of the
arabinose-inducible araBAD promoter.
A BglII linker was inserted at amino acid position 148 in the flu gene according to
the following procedure: plasmid pKKJ143 was used as the template for PCR with
primers KK70 and HH184 (5-CCCAGATCTATCCGGTCCCCCTTCCG) and
with primers HH185 (5-GGGAGATCTAACGGTGATACCGGGCAGTT) and
KK39. The PCR products were cleaved with XhoI and BglII and with BglII and
HindIII. In a triple ligation, both PCR fragments obtained were inserted into the
XhoI and HindIII sites of pBAD/myc-HisA to produce pKKJ135 (Fig. 1).
Two oligonucleotides, KK3 (5-GATCTGTTGAAGTTCCGGGATCCCAGC
ATATCGATAGTCAGAAAAAAGCTA) and KK4 (5-GATCTAGCTTTTTT
CTGACTATCGATATGCTGGGATCCCGGAACTTCAACA), encoding ami-
no acids 50 to 64 of the cholera toxin B chain (CTB), were designed so that they
contained an internal BamHI site at amino acid position 54 and were flanked
with BglII overhangs. These oligonucleotides were annealed, phosphorylated,
and ligated into pKKJ135 digested with BglII. The resultant plasmid (pKKJ136)
was checked by BamHI digestion and sequencing. In a similar procedure, two
oligonucleotides, KK12 (5-GATCTAAAGAACCGAACAAAGGCGTTAATC
CGGATGAAGTTG) and KK13 (5-GATCCAACTTCATCCGGATTAACGC
CTTTGTTCGGTTCTTTA), encoding a 12-amino-acid linear epitope sequence
of Chlamydia trachomatis DnaK, Chlam12 (3), flanked by BglII and BamHI sites,
were introduced into the BglII site of pKKJ135 to produce pKKJ138 (Fig. 1).
Construction of fimH-flu fusion. The sector encoding the signal peptide and
the first 156 amino acids of fimH was amplified with primers KK85 (5-CGCG
CTCGAGATAAGAAGAGAGGATTGTAATGAAAC) and HH190 (5-CCC
AGATCTGCCGCCAGTAGGCACCACCA). The resulting fragment was cut
with XhoI and BglII and inserted directly into the XhoI and BglII sites of
pKKJ135 to produce plasmid pKKJ146. In this construct, the initial 199 codons
of the flu gene are replaced with the first 177 codons of fimH, i.e., the signal
peptide and lectin domain.
DNA manipulations. Isolation of plasmid DNA was carried out with the QIA-
prep Spin miniprep kit (Qiagen). Restriction endonucleases were used according
to the manufacturer’s specifications (Biolabs). PCRs were done as previously
described (47). Amplified products were sequenced to ensure fidelity of the PCR
with the ABI Prism BigDye Terminator cycle sequencing ready reaction kit (PE
Applied Biosystems). Samples were run on a Perkin-Elmer ABI Prism 310
genetic analyzer (PE Applied Biosystems) as described in the manufacturer’s
specifications.
Colony morphology. Colony morphology was examined by with a Carl Zeiss
Axioplan epifluorescence microscope, and digital images were captured with a
12-bit cooled slow-scan charge-coupled device camera (KAF 1400 chip; Photo-
metrics, Tucson, Ariz.) controlled by the PMIS software (Photometrics).
Immunofluorescence microscopy. Surface presentation of Ag43, Ag43-CTP3,
Ag43-Chlam12, and Ag43-FimH was assessed by immunofluorescence micros-
copy with antibodies directed against the -subunit of Ag43 (raised by T.
Chakraborty, University of Giessen, Giessen, Germany), CTB (47), Chlam12
(kindly donated by S. Birkelund, University of Aarhus, Aarhus, Denmark) (3), or
FimH (kindly provided by E. Sokurenko, University of Washington, Seattle).
Cell fixation, immunolabeling, and microscopy were carried out as previously
described (43) with a fluorescein isothiocyanate (FITC)-labeled secondary anti-
body. Surface-associated FimH receptor activity was assessed by receptor fluo-
rescence microscopy with D-mannose–bovine serum albumin (BSA)–biotin and
FITC-conjugated streptavidin.
Western immunoblotting. Samples were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinyli-
dene difluoride microporous membrane filters as described previously (47). Re-
constituted dried skimmed milk (10% [wt/vol]) was used as the blocking reagent,
and serum raised against the -subunit of Ag43 or FimH was used as the primary
serum. Peroxidase-conjugated anti-rabbit immunoglobulin serum was used as the
secondary antibody.
Receptor blot. Receptor blots of FimH-Ag43 fusions were carried out essen-
tially as described previously (45). D-mannose coupled to BSA was used as the
primary reagent. Specific D-mannose binding was visualized by incubating the
filter with anti-BSA rabbit serum and subsequently with horseradish peroxidase-
conjugated anti-rabbit immunoglobulin serum. Tetramethylbenzidine was used
as the substrate.
Release and purification of Ag43 chimeric fusion proteins. Overnight cultures
of the strains were inoculated in fresh LB supplemented with 0.2% arabinose and
appropriate antibiotics and grown to identical optical densities at 600 nm
(OD600; 2.5). Cells were harvested by centrifugation and gently washed in cold
phosphate-buffered saline, and the centrifugation tube was placed in a 60°C
water bath for 10 min in order to release the Ag43 -fragment. Cells were
immediately removed by centrifugation, and the proteins in the supernatant were
precipitated with acetone (75%, vol/vol). The pellet was dried and resuspended
in 0.1 M Tris buffer (pH 8).
RESULTS
Construction of recombinant gene fusions. Recently we sub-
jected the flu gene to linker insertion mutagenesis in connec-
tion with structure-function studies of Ag43 (unpublished
FIG. 1. Overview of the plasmid constructs used in this study (not
drawn to scale). Checkered boxes represent the flu signal peptide, and
shaded boxes represent heterologous sequences: CTP3 epitope se-
quence (black box), Chlam12 epitope sequence (gray box), and
FimH1-177 (light gray box).
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant characteristics Reference
Escherichia coli K-12
HEHA16
BD1428; fim::kan flu 27
Salmonella enterica
SL5325
aroA rfaJ989 39
Plasmids
pBAD/myc-HisA 17
pKKJ143 flu gene in pBAD/myc-HisA This study
pKKJ135 pKKJ143 with BglII site in flu gene This study
pKKJ136 CTP3 epitope in BglII site of
pKKJ135
This study
pKKJ138 Chlam12 epitope in BglII site of
pKKJ135
This study
pKKJ146 fimH lectin domain in XhoI/BglII
sites of pKKJ135
This study
pMAS4 fimH gene in pBR322 46
4198 KJÆRGAARD ET AL. J. BACTERIOL.
 o
n
 O
ctober 13, 2015 by University of Queensland Library
http://jb.asm.org/
D
ow
nloaded from
 
data). One of the findings from these studies was that in-frame
insertion of a BglII linker (encoding Arg-Ser) in front of the
codon corresponding to amino acid 148 in the -subunit of
Ag43 did not affect the production, surface location, or auto-
aggregation of Ag43. This observation led us to believe that
position 148 in Ag43 could be suitable for insertion and display
of heterologous sequences on the surface of E. coli.
In order to investigate this tenet, two different well-charac-
terized epitope sequences, CTP3 and Chlam12, were chosen as
heterologous passenger sequences and introduced into Ag43.
The CTP3 epitope, comprising amino acids 50 to 64 of the
CTB chain, is known to comprise a conformational loop on the
surface of CTB and has previously been shown by us to be
authentically displayed on bacterial surfaces after fusion to
different surface proteins (43, 47). A synthetic DNA segment
encoding the CTP3 loop was made by annealing two comple-
mentary 51-base oligonucleotides which were designed to con-
tain BglII overhangs in order to allow insertion into the BglII
linker in the flu gene (Fig. 1). In a similar manner, a 12-amino-
acid linear epitope, KEPNKGVNPDEV (presently called
Chlam12), of Chlamydia trachomatis DnaK protein was intro-
duced in front of position 148 in Ag43 (Fig. 1) The Chlam12
epitope is specifically recognized by the monoclonal anti-
body MAb35.2 (3). The tightly regulated arabinose-induc-
ible araBAD promoter was used for expression of the gene
fusions (17).
We have previously shown that the physical presence of type
1 fimbriae on the E. coli cell surface blocks Ag43-mediated
autoaggregation (19). In order to abolish any interference from
type 1 fimbriae, the plasmid constructs were transformed into
a fim flu double mutant (HEHA16) of E. coli BD1428 (27).
Ag43 function is unaffected by insertion of heterologous
sequences. The phenotypic hallmarks of Ag43 expression are
induction of a frizzy colony morphology and autoaggregation
of cells (19, 27). To investigate whether insertion of heterolo-
gous peptides influenced the functionality of Ag43, we exam-
ined these parameters. When cells containing plasmids
pKKJ136 (Ag43-CTP3) and pKKJ138 (Ag43-Chlam12) were
grown on arabinose-containing solid medium, distinct frizzy
colony morphotypes were observed, similar to that of cells
expressing wild-type Ag43 (pKKJ143) (Fig. 2). No change in
colony morphology was observed in control experiments where
the cells were grown in the absence of arabinose. Also, when
cells harboring pKKJ136 or pKKJ138 were left standing after
growth in liquid medium in the presence of arabinose, they
were observed to autoaggregate and settle exactly like the
wild-type control (data not shown). Taken together, the results
indicated that the fusion proteins were presented on the cell
surface and that introduction of the heterologous sequences
did not interfere with the functionality of Ag43.
Expression and processing of Ag43-CTP3 and Ag43-
Chlam12 fusion proteins. The amount of Ag43 protein pro-
duced by the clones was examined by SDS-PAGE and Western
immunoblotting after arabinose induction. A band migrating at
the expected apparent molecular mass for the Ag43 -frag-
ment (50 kDa) was observed from hosts carrying plasmid
pKKJ143 or pKKJ135, and bands migrating with slightly higher
apparent molecular masses were seen in the case of plasmids
encoding the fusion proteins, i.e., pKKJ136 (Ag43-CTP3) and
pKKJ138 (Ag43-Chlam12) (Fig. 3A). Also, the presence of
foreign inserts seemed to have little influence on the level of
Ag43 produced and on the correct processing of Ag43 into -
and -subunits (Fig. 3A).
Passenger epitopes are authentically presented on the cell
FIG. 2. Colony morphology of cells examined by phase contrast microscopy after overnight growth on solid medium with () and without ()
0.2% arabinose. (A) Recombinant E. coli strain HEHA16; (B) recombinant S. enterica strain SL5325. Strains expressing both wild-type and
chimeric versions of Ag43 have frizzy colony morphologies except in the case of plasmid pKKJ146. No change in morphology was observed for a
strain containing the control plasmid, pBAD/myc-HisA. Colonies were photographed at the same magnification.
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surface in the context of the Ag43 fusion proteins. The results
obtained regarding the colony morphology and autoaggrega-
tion of the strains expressing the Ag43-CTP3 and Ag43-
Chlam12 chimeras prompted us to investigate more directly
the surface display of the chimeras and, notably, whether the
passenger epitopes were accessible and exposed in authentic
conformations. This was carried out by immunofluorescence
microscopy with antibodies directed against Ag43 and the
CTP3 and Chlam12 epitopes. Ag43 antiserum readily reacted
with cells harboring plasmids pKKJ143, pKKJ135, pKKJ136,
and pKKJ138, again demonstrating that the Ag43 chimeras
were translocated to the cell surface (Fig. 4). Furthermore,
antibodies directed against the passenger epitopes were seen
to specifically recognize cells expressing the corresponding fu-
sion proteins, indicating that the CTP3 and Chlam12 epitopes
were indeed not only accessible on the cell surface but also
authentically folded in the context of the Ag43 scaffold (Fig. 5).
No reactions against the passenger epitope sera were seen in
control experiments with either wild-type Ag43 or vector con-
trols.
Expression of Ag43 chimeras in Salmonella strains. Atten-
uated Salmonella strains have been shown to be effective live
vaccine strains and candidates for recombinant vaccine deliv-
ery systems (31, 40, 48). We have previously shown that Ag43
can be transported to and displayed on the surface of a wide
range of gram-negative bacteria (27). This prompted us to
investigate the possibility of expressing our Ag43 chimeras in
the aroA-attenuated S. enterica serovar Typhimurium refer-
ence strain SL5325 with a view to demonstrating Ag43-medi-
ated foreign antigen display in a bona fide live vaccine strain.
Strain SL5325 forms nonfrizzy colonies and does not autoag-
gregate (Fig. 2B). Transformation of SL5325 with pKKJ143,
pKKJ135, pKKJ136, and pKKJ138 gave rise to colonies with
the characteristic frizzy morphology associated with Ag43 sur-
face presentation after induction (Fig. 2B). Furthermore, ar-
abinose-induced cultures of the transformed SL5325 clones
FIG. 3. Western immunoblot of total cell lysates of (A) recombi-
nant E. coli strain HEHA16 and (B) recombinant S. enterica strain
SL5325 containing plasmids pBAD/myc-HisA, pKKJ143, pKKJ135,
pKKJ136, and pKKJ138 (lanes 1 to 5, respectively). The position of
Ag43 protein is indicated.
FIG. 4. Immunofluorescence microscopy showing surface presentation of Ag43 on recombinant E. coli HEHA16 cells and S. enterica SL5325
cells. Phase contrast microscopy (the left panels on each side) and fluorescence microscopy (right panels on each side) were performed. To detect
the presence of Ag43 on the cell surface, a polyclonal rabbit serum raised against the -subunit of Ag43 was used, and this was detected by
FITC-labeled anti-rabbit immunoglobulin serum.
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readily autoaggregated in line with the corresponding E. coli
clones (data not shown).
The amount of Ag43 produced and the processing of Ag43
(both wild-type and chimeric versions), as assessed by SDS-
PAGE and Western immunoblotting, were similar in SL5325
and E. coli (Fig. 3). Furthermore, immunofluorescence micros-
copy revealed that Ag43 and the passenger epitopes (CTP3
and Chlam12) were displayed in an accessible and conforma-
tionally authentic form on the surface of SL5325 (Fig. 4 and
Fig. 5A and B). The results suggest that Ag43 can be used to
display foreign immunogenic determinants on the surface not
only of E. coli but also of a relevant live vaccine strain.
Ag43 display of a foreign functional protein domain, the
lectin moiety of FimH. Having demonstrated Ag43-mediated
display of small heterologous passenger peptides of 12 to 15
amino acids, we decided to investigate whether Ag43 was ca-
pable of accommodating and displaying entire protein do-
mains. For this purpose, we selected the N-terminal domain of
a well-characterized bacterial adhesin, FimH, as a model. Im-
munization with purified FimH has shown promise for preven-
tion of E. coli urinary tract infections (33). FimH is the 279-
amino-acid mannose-recognizing adhesin of type 1 fimbriae. It
consists of two domains, a lectin domain encompassing the
N-terminal 156 amino acid residues, linked to the C-terminal
organelle integration domain via a short tetrapeptide loop. We
have previously manipulated the fimH gene and shown that the
FimH lectin domain can be expressed and purified as a stable,
functional entity from the periplasm of E. coli (45).
In order to create a FimH-Ag43 chimera, the first 199
codons of flu, i.e., the sector upstream of position 148, were
replaced with the first 177 codons of fimH, i.e., signal peptide
plus lectin domain, and placed downstream of the pBAD pro-
moter (Fig. 1). E. coli host cells harboring this construct
(pKKJ146) were seen to exhibit a peculiar nonfrizzy colony
morphology after induction (Fig. 2), but the cells were unable
to autoaggregate. Analysis of lysates of cells harboring
pKKJ146 by SDS-PAGE and Western immunoblotting with
antisera raised against FimH revealed a protein band with an
apparent molecular mass of 52 kDa, in accordance with the
expected size of the FimH-Ag43 fusion product, i.e., 514
amino acid residues (Fig. 6A). The ability of the fusion protein
to recognize D-mannose was assayed by receptor blotting of
whole-cell lysates (see Materials and Methods). The FimH-
Ag43 chimera was found to recognize D-mannose, indicating
that the fusion protein retained the FimH receptor recognition
faculty (Fig. 6B).
Ag43-assisted surface display of the lectin moiety of FimH.
Fluorescence microscopy was used to establish surface presen-
tation of the FimH-Ag43 fusion product. Cells containing plas-
mid pKKJ146 were seen to react with both anti-FimH serum
and anti-Ag43 serum (Fig. 7). Additionally, the functionality of
the FimH lectin moiety was assessed by receptor fluorescence
FIG. 5. Immunofluorescence microscopy showing surface presentation of CTP3 epitope sequence (A) and Chlam12 epitope sequence (B) on
recombinant E. coli HEHA16 and S. enterica SL5325 cells. Phase contrast microscopy (the left panels on each side) and fluorescence microscopy
(right panels on each side) were performed. To detect the presence of CTP3 on the cell surface, a polyclonal rabbit serum raised against CTP3
was used, and this was detected by FITC-labeled anti-rabbit immunoglobulin serum. To detect the presence of Chlam12 on the cell surface, a
monoclonal antibody raised against Chlam12 was used, and this was detected by FITC-labeled anti-mouse immunoglobulin serum.
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microscopy with D-mannose-coupled BSA as the receptor tar-
get (Fig. 7). The results indicate that the lectin domain of
FimH is presented on the bacterial surface in a functional form
in the context of the FimH-Ag43 fusion.
Ag43 chimeras can be liberated from carrier cells and pu-
rified. The -subunit of wild-type Ag43 is attached to the cell
surface via noncovalent interaction with the -subunit but can
be released by brief heating to 60°C. In order to test whether
this faculty was conserved in the chimeric versions of Ag43,
identical aliquots of host cells expressing our chimeric Ag43 as
well as adequate controls were processed to release the Ag43
-subunits and subsequent protein isolation (see Materials and
Methods). SDS-PAGE revealed that the Ag43 chimeras in all
cases were released and could be purified from the superna-
tants in yields comparable to that of wild-type Ag43 (Fig. 6C)
DISCUSSION
The double membrane system of gram-negative bacteria
constitutes a formidable barrier for proteins destined for the
cell exterior. However, the bacteria have over eons developed
various systems to route proteins through this obstacle. Five
major systems can be distinguished: type I, of which E. coli
hemolysin is a key example; type II, exemplified by the pullu-
lanase system of Klebsiella; type III, required for translocation
of some of the components of the secretion machinery; type
IV, exemplified by the Agrobacterium tumefaciens T-DNA de-
livery system; and finally the type V system, comprising the
autotransporter protein family (reviewed in references 21 and
35). By these systems, a range of proteins can reach the cell
exterior, where they are key players in a number of natural
processes, such as adhesion, biofilm formation, motility, and
cell aggregation.
However, many proteins of interest in medicine and biotech-
nology are neither surface displayed nor of bacterial origin. An
attractive way to display such proteins or segments thereof on
the bacterial surface is to graft them into permissible positions
on naturally occurring surface proteins. Autotransporter pro-
teins, of which Ag43 is a paradigm, do not require auxiliary
proteins (e.g., periplasmic chaperones), as many other systems
do. This inherent simplicity makes them obvious candidates for
scaffold-assisted surface display of foreign proteins or protein
segments.
Our data indicate that Ag43 can act as a versatile scaffold for
surface display of heterologous inserts and that the system
offers a number of interesting features. (i) Ag43 can accom-
modate and display correctly folded foreign inserts. (ii) Ag43 is
able to display entire and functional protein domains. (iii)
Ag43 is a high-valency display system, i.e., the high copy num-
ber of wild-type Ag43 (50,000 copies per cell) does not seem
to be significantly affected by foreign inserts or change of host
strain. (iv) The carriage of passenger peptides does not inter-
fere with correct processing of Ag43 into - and -moieties. (v)
Ag43 can be displayed in a wide range of gram-negative bac-
teria.
Two immunogenic reporter epitopes, CTP3 and Chlam12,
FIG. 6. Western immunoblot and receptor blot of total whole-cell
lysate of recombinant cells with anti-FimH serum (A) and mannose-
BSA (B). The apparent molecular size of the FimH-Ag43 fusion pro-
tein is indicated. (C) Coomassie brilliant blue-stained SDS-PAGE gel
of wild-type and chimeric Ag43 -modules released from the cell
surface of E. coli strain HEHA16 containing plasmid pBAD/myc-
HisA, pKKJ143, pKKJ135, pKKJ136, pKKJ138, or pKKJ146 (lanes 1
to 6, respectively).
FIG. 7. Immunofluorescence microscopy showing surface presentation and receptor functionality of the FimH-Ag43 fusion protein on recom-
binant E. coli HEHA16 cells. Cells expressing plasmids pKKJ146 and pKKJ143 were reacted with primary antibodies directed against Ag43 and
FimH, respectively, and FITC-labeled secondary antibody was used for detection. Additionally, receptor functionality was probed by using
mannose-BSA-biotin, which was subsequently detected by FITC-conjugated streptavidin.
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were displayed on the bacterial surface in the context of Ag43
and shown by immunofluorescence microscopy to be authen-
tically folded. The presence of the foreign inserts did not in-
terfere with either the yield or functionality of the carrier
protein. This prompted us to investigate the possibility of dis-
playing an entire protein domain with the Ag43 system. The
D-mannose-specific lectin moiety of FimH was chosen as a
candidate domain for this purpose due to its well-characterized
binding features and its promise as a candidate vaccine against
urinary tract-infectious E. coli. The FimH lectin moiety was
surface displayed in the context of the FimH-Ag43 chimera
and presented in a functional configuration, as evidenced by its
affinity for a cognate receptor target, D-mannose–BSA. Unlike
other Ag43 constructs, FimH-Ag43 did not give rise to a frizzy
colony morphology, and cells were unable to autoaggregate. It
might be that the frizzy colony morphology is dependent on
cell-to-cell aggregation and that this faculty depends on struc-
tural information residing in the segment encompassing the
N-terminal 148 amino acids of the Ag43 -subunit.
FimH contains two disulfide bridges, one of which is located
in the lectin moiety. Disulfide bridge formation of fimbrial
structural proteins has been demonstrated to take place in the
periplasm (15, 26). During biogenesis, the structural compo-
nents are to a large extent folded before final translocation to
the cell exterior (25, 49). Accordingly, the FimH lectin moiety
in the FimH-Ag43 fusion is probably extensively folded before
the final Ag43 -subunit-assisted transit to the cell exterior
takes place. The FimH lectin domain forms an ellipsoid struc-
ture with a width of 2.5 nm (7). Although Ag43 does not
possess cysteine bridges itself, the presence of such features in
a heterologous passenger domain is apparently not incompat-
ible with traverse of the membrane system and surface display.
A similar observation was noted with another autotransporter,
the immunoglobulin A protease of Neisseria gonorrhoeae (52).
Wild-type Ag43 is processed into an - and a -subunit,
presumably by autocatalysis. The -subunit contains a se-
quence similar to that of the consensus sequence for the active
site of aspartyl proteases, LLADSGAAVSGT (44), at amino
acid positions 335 to 346. The present constructs were engi-
neered to contain foreign inserts in front of amino acid posi-
tion 148, leaving the potential protease site intact. All of our
engineered Ag43 versions were processed into - and -sub-
units of expected sizes, lending further credence to the tenet of
autocatalytic processing of Ag43. The fact that the Ag43 chi-
meras are not only surface displayed on bacteria but can ad-
ditionally be released by simple heat treatment and purified
offers several advantages. In a vaccine context, this offers ca-
pabilities for both live and component vaccine development
approaches. In the current FimH-based candidate vaccine,
FimH is purified as a complex with the FimC chaperone from
the periplasm of E. coli hosts (33), a rather tedious procedure
in comparison. Here we suggest two easy modes: an easy-to-
purify component vaccine and a live vaccine candidate strain.
We have previously demonstrated that Ag43 can be surface
exposed in a functional form in many gram-negative bacteria
(27). This faculty is here demonstrated in a Salmonella strain,
the potential vaccine candidate strain SL5325. Aromatic-de-
pendent Salmonella strains have been demonstrated to be
highly efficient live vaccine strains in many contexts (31, 40,
48). The apparent efficiency with which the Ag43 chimeras
were displayed in the aroA-attenuated SL5325 strain bodes
well for the development of new efficient live vaccine strains
combining the excellent features of both systems.
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